These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

734 related items for PubMed ID: 17920999

  • 1. Post-transplant infections: single center experience from the developing world.
    Ullah K, Raza S, Ahmed P, Chaudhry QU, Satti TM, Ahmed S, Mirza SH, Akhtar F, Kamal K, Akhtar FM.
    Int J Infect Dis; 2008 Mar; 12(2):203-14. PubMed ID: 17920999
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.
    Levine JE, Wiley J, Kletzel M, Yanik G, Hutchinson RJ, Koehler M, Neudorf S.
    Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008
    [Abstract] [Full Text] [Related]

  • 7. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Jan; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic peripheral blood stem cell transplantations in children--a single center experience.
    Sufliarska S, Horáková J, Bodová I, Martinka J, Hrubisko M, Kovács L, Jancovicová K, Lukác J.
    Neoplasma; 2004 Jan; 51(2):110-6. PubMed ID: 15190420
    [Abstract] [Full Text] [Related]

  • 9. Peripheral blood stem cell transplantation in children with beta-thalassemia major.
    Farzana T, Shamshi TS, Irfan M, Ansari SH, Baig MI, Shakoor N.
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):204-6. PubMed ID: 12718774
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M.
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [Abstract] [Full Text] [Related]

  • 12. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.
    Robin M, Guardiola P, Dombret H, Baruchel A, Esperou H, Ribaud P, Devergie A, Gluckman E, Socié G.
    Bone Marrow Transplant; 2003 May; 31(10):877-87. PubMed ID: 12748664
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
    Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N, Chehata S, Esperou H, Vernant JP, Michallet M, Buzyn A, Gratecos N, Cahn JY, Bourhis JH, Chir Z, Raffoux C, Socié G, Golmard JL, Jouet JP, French Society of Bone Marrow Transplantation and Cell Therapy.
    J Clin Oncol; 2006 Dec 20; 24(36):5695-702. PubMed ID: 17116940
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
    Shereck EB, Cooney E, van de Ven C, Della-Lotta P, Cairo MS.
    Pediatr Blood Cancer; 2007 Sep 20; 49(3):306-12. PubMed ID: 16972242
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic hematopoietic stem cell transplantation in patients 50 years of age and older.
    de la Cámara R, Alonso A, Steegmann JL, Arranz R, Granados E, Rodríguez-Macías G, Sanz-Rodríguez C, de Soria VG, Figuera A, Fernández-Rañada JM.
    Haematologica; 2002 Sep 20; 87(9):965-72. PubMed ID: 12217809
    [Abstract] [Full Text] [Related]

  • 19. Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
    Uzunel M, Remberger M, Sairafi D, Hassan Z, Mattsson J, Omazic B, Barkholt L, Ringdén O.
    Transplantation; 2006 Oct 15; 82(7):913-9. PubMed ID: 17038906
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.